ATOPIC DERMATITIS PATIENTS

Clinical trials for ATOPIC DERMATITIS PATIENTS explained in plain language.

Never miss a new study

Get alerted when new ATOPIC DERMATITIS PATIENTS trials appear

Sign up with your email to follow new studies for ATOPIC DERMATITIS PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New skin treatment begins human safety testing

Disease control Completed

This early-stage study tested the safety and how the body processes a new drug called IBI356 for atopic dermatitis (eczema). Researchers gave the drug to 99 healthy volunteers and people with moderate-to-severe eczema to check for side effects and measure drug levels in the blood…

Matched conditions: ATOPIC DERMATITIS PATIENTS

Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ATOPIC DERMATITIS PATIENTS

Get alerted when new ATOPIC DERMATITIS PATIENTS trials appear

New skin treatment begins human safety testing